Search

Your search keyword '"Classe, Jean-Marc"' showing total 447 results
Start Over Author "Classe, Jean-Marc"
447 results on '"Classe, Jean-Marc"'

1. The Influence of Surgical Complexity and Center Experience on Postoperative Morbidity After Minimally Invasive Surgery in Gynecologic Oncology: Lessons Learned from the ROBOGYN-1004 Trial

Author

Lambaudie, Eric, Bogart, Emilie, Le Deley, Marie-Cécile, EL Hajj, Houssein, Gauthier, Tristan, Hebert, Thomas, Collinet, Pierre, Classe, Jean Marc, Lecuru, Fabrice, Motton, Stephanie, Conri, Vanessa, Ferrer, Catherine, Marchal, Frederic, Ferron, Gwenael, Probst, Alicia, Jauffret, Camille, and Narducci, Fabrice

Published
2024
Full Text
View/download PDF

2. Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial

Author

Classe, Jean-Marc, Meeus, Pierre, Hudry, Delphine, Wernert, Romuald, Quenet, François, Marchal, Frédéric, Houvenaeghel, Gilles, Bats, Anne-Sophie, Lecuru, Fabrice, Ferron, Gwenaël, Brigand, Cécile, Berton, Dominique, Gladieff, Laurence, Joly, Florence, Ray-Coquard, Isabelle, Durand-Fontanier, Sylvaine, Liberale, Gabriel, Pocard, Marc, Georgeac, Constantin, Gouy, Sébastien, Guilloit, Jean-Marc, Guyon, Frédéric, Costan, Cristina, Rousselet, Jean-Marc, de Guerké, Lara, Bakrin, Naoual, Brument, Emilie, Martin, Elodie, Asselain, Bernard, Campion, Loïc, and Glehen, Olivier

Published
2024
Full Text
View/download PDF

7. Multicentric development and evaluation of 18F-FDG PET/CT and MRI radiomics models to predict para-aortic lymph node involvement in locally advanced cervical cancer

Author

Lucia, François, Bourbonne, Vincent, Pleyers, Clémence, Dupré, Pierre-François, Miranda, Omar, Visvikis, Dimitris, Pradier, Olivier, Abgral, Ronan, Mervoyer, Augustin, Classe, Jean-Marc, Rousseau, Caroline, Vos, Wim, Hermesse, Johanne, Gennigens, Christine, De Cuypere, Marjolein, Kridelka, Frédéric, Schick, Ulrike, Hatt, Mathieu, Hustinx, Roland, and Lovinfosse, Pierre

Published
2023
Full Text
View/download PDF

10. Contribution of endocrine therapy in oestrogen receptor-positive pT1a-b breast cancer: Results of a retrospective study

Author

Houvenaeghel, Gilles, de Nonneville, Alexandre, Cohen, Monique, Classe, Jean-Marc, Reyal, Fabien, Mazouni, Chafika, Faure, Christelle, Martinez, Alejandra, Chauvet, Marie-Pierre, Daraï, Emile, Coutant, Charles, Colombo, Pierre-Emmanuel, Gimbergues, Pierre, Azuar, Anne-Sophie, Rouzier, Roman, Tunon de Lara, Christine, Crochet, Patrice, Rua, Sandrine, and Gonçalves, Anthony

Published
2022
Full Text
View/download PDF

11. Optimal timing of interval debulking surgery for advanced epithelial ovarian cancer: A retrospective study from the ESME national cohort

Author

Thomas, Quentin Dominique, Boussere, Amal, Classe, Jean-Marc, Pomel, Christophe, Costaz, Hélène, Rodrigues, Manuel, Ray-Coquard, Isabelle, Gladieff, Laurence, Rouzier, Roman, Rouge, Thibault De La Motte, Gouy, Sébastien, Barranger, Emmanuel, Sabatier, Renaud, Floquet, Anne, Marchal, Frédéric, Guillemet, Cécile, Polivka, Valentine, Martin, Anne-Laure, Colombo, Pierre-Emmanuel, and Fiteni, Frédéric

Published
2022
Full Text
View/download PDF

13. Eligibility for Adjuvant Cyclin-Dependent Kinase 4/6 Inhibitors in Endocrine Receptor-Positive and HER2-Negative Early Breast Cancer by Age and Type of Surgery.

Author

Houvenaeghel, Gilles, Classe, Jean-Marc, Chauvet, Marie-Pierre, Colombo, Pierre-Emmanuel, Jouve, Eva, Reyal, Fabien, Daraï, Emile, Rouzier, Roman, Faure-Virelizier, Christelle, Gimbergues, Pierre, Coutant, Charles, Mazouni, Chafika, Azuar, Anne-Sophie, Martino, Marc, Bouteille, Catherine, Cohen, Monique, and de Nonneville, Alexandre

Subjects
*BREAST cancer prognosis, *BREAST tumors, *PROTEIN-tyrosine kinase inhibitors, *AGE distribution, *RETROSPECTIVE studies, *TUMOR grading, *ADJUVANT chemotherapy, *ONCOGENES, *HORMONE therapy, *MEDICAL records, *ACQUISITION of data, *CYCLIN-dependent kinases, *LUMPECTOMY, *CHEMICAL inhibitors
Abstract

Simple Summary: Improved outcomes have been reported with adjuvant treatment combining cyclin-dependent kinase 4/6 inhibitors with endocrine therapy, in high-risk patients with ER-positive and HER2-negative breast cancer, regardless of age. In this real-world data analysis, MonarchE and NataLEE high-risk patients accounted for 9.5% and 33% of patients undergoing upfront surgery, respectively. Significantly higher eligibility rates were observed in patients who underwent a mastectomy, >70 years and ≤40 years for adjuvant abemaciclib and ribociclib, and in patients >80 years for ribociclib. A higher discontinuation rate for abemaciclib was reported in patients ≥65 years and it can be assumed that discontinuation rates may increase with more older patients. If the results of the NataLEE trial translate into clinical practice, the number of patients potentially eligible for adjuvant CDK4/6 inhibitors may increase, especially in the elderly population. Background: Despite early diagnosis, approximately 20% of patients with ER-positive and HER2-negative breast cancer (BC) will experience disease recurrence. Improved survival has been reported with adjuvant treatment combining cyclin-dependent kinase 4/6 inhibitors with endocrine therapy, in high-risk patients with ER-positive and HER2-negative BC, regardless of age. Older patients have higher rates of ER-positive/HER2-negative BC than younger patients. Methods: In this real-world data analysis, MonarchE and NataLEE high-risk patients accounted for 9.5% and 33% of patients undergoing upfront surgery, respectively. Significantly higher eligibility rates were observed in patients who underwent a mastectomy, >70 years and ≤40 years for adjuvant abemaciclib and ribociclib, and in patients >80 years for ribociclib. Results: Eligibility rates in patients ≤40 years and >80 years who underwent mastectomy were 27.8% and 24.7% for abemaciclib, respectively, and 56.6% and 65.2% for ribociclib, respectively. A higher discontinuation rate for abemaciclib was reported in patients aged ≥65 years and it can be assumed that discontinuation rates may increase in even older patients. Conclusions: If the results of the NataLEE trial translate into clinical practice, the number of patients potentially eligible for adjuvant CDK4/6 inhibitors may increase, especially in the elderly population. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

15. Omission of lymphadenectomy in patients with advanced epithelial ovarian cancer treated with primary or interval cytoreductive surgery after neoadjuvant chemotherapy: The CARACO phase III randomized trial.

Author

Classe, Jean-Marc, primary, Campion, Loic, additional, Lecuru, Fabrice, additional, Vergote, Ignace, additional, Jankowski, Clémentine, additional, Wernert, Romuald, additional, Pomel, Christophe, additional, Houvenaeghel, Gilles, additional, Dupre, Pierre-Francois, additional, Mathevet, Patrice, additional, Villet, Richard, additional, Joly, Florence, additional, Berton, Dominique, additional, Debeaupuis, Emilie, additional, Frenel, Jean-Sebastien, additional, and Loaec, Cecile, additional

Published
2024
Full Text
View/download PDF

18. Clinicopathological characterization of a real-world multicenter cohort of endometrioid ovarian carcinoma: Analysis of the French national ESME-Unicancer database

Author

De Nonneville, Alexandre, Zemmour, Christophe, Frank, Sophie, Joly, Florence, Ray-Coquard, Isabelle, Costaz, Hèlène, Classe, Jean-Marc, Floquet, Anne, De la Motte Rouge, Thibault, Colombo, Pierre-Emmanuel, Sauterey, Baptiste, Leblanc, Eric, Pomel, Christophe, Marchal, Frédéric, Barranger, Emmanuel, Savoye, Aude-Marie, Guillemet, Cécile, Petit, Thierry, Pautier, Patricia, Rouzier, Roman, Gladieff, Laurence, Simon, Gaëtane, Courtinard, Coralie, and Sabatier, Renaud

Published
2021
Full Text
View/download PDF

20. Recommandations francophones pour la pratique clinique concernant la prise en charge des cancers du sein de Saint-Paul-de-Vence 2022-2023

Author

Aapro, Matti, Al-Ghazali, Hesham, Bachelot, Thomas, Barranger, Emmanuel, Berrada, Narjiss, Bidard, François-Clément, Bounedjar, Adda, Boussen, Hamouda, Campone, Mario, Cardoso, Fatima, Ceugnart, Luc, Classe, Jean-Marc, Cohen, Monique, Coutant, Charles, Cutuli, Bruno, Dalenc, Florence, Dieras, Véronique, Dohollou, Nadine, Giacchetti, Sylvie, Goncalves, Anthony, Freyer, Gilles, Hannoun-Levi, Jean-Michel, Hardy-Bessard, Anne-Claire, Jacquin, Jean-Philippe, Jacot, William, Kerrou, Khaldoun, Ladoire, Sylvain, Lerebours, Florence, Levy, Christelle, Llombart-Cussac, Antonio, Loirat, Delphine, Thomassin, Isabelle, Piccart, Martine, Petit, Thierry, Radosevic-Robin, Nina, Rotenberg, Luc, Rouzier, Roman, Salmon, Rémy, Vincent-Salomon, Anne, Spano, Jean-Philippe, Tallet, Agnès, Teixera, Luis, Tredan, Olivier, Verret, Benjamin, Zarca, Daniel, Zelek, Laurent, Zerbib, Eric, Gligorov, Joseph, Benderra, Marc-Antoine, Barthere, Xavier, de Forceville, Louise, Antoine, Eric Charles, Cottu, Paul Henri, Delaloge, Suzette, Pierga, Jean-Yves, Belkacemi, Yazid, Houvenaegel, Gilles, Pujol, Pascal, Rivera, Sofia, Spielmann, Marc, Penault-Llorca, Frédérique, and Namer, Moise

Published
2023
Full Text
View/download PDF

21. Omission of Completion Axillary Lymph Node Dissection for Patients with Breast Cancer Treated by Upfront Mastectomy and Sentinel Node Isolated Tumor Cells or Micrometastases.

Author

Houvenaeghel, Gilles, Heinemann, Mellie, Classe, Jean-Marc, Bouteille, Catherine, Gimbergues, Pierre, Azuar, Anne-Sophie, Martino, Marc, Tallet, Agnès, Cohen, Monique, and de Nonneville, Alexandre

Subjects
BREAST cancer prognosis, BREAST tumors, MICROMETASTASIS, AXILLARY lymph node dissection, DESCRIPTIVE statistics, MULTIVARIATE analysis, LONGITUDINAL method, MASTECTOMY, PROGRESSION-free survival, OVERALL survival
Abstract

Simple Summary: Omission of completion axillary lymph node dissection (cALND) in patients undergoing mastectomy with sentinel node (SN) isolated tumor cells (ITC) or micrometastases is discussed. We evaluated the impact of cALND omission on survival in breast cancer (BC) patients treated by mastectomy with SN ITC or micrometastases. Among 554 BC, the non-SN involvement rate was 13.2%. With a median follow-up of 66.46 months, multivariate analysis showed that cALND omission was significantly associated with overall survival (OS, HR: 2.583, p = 0.043), disease-free survival (DFS, HR: 2.538, p = 0.008), and metastasis-free survival (MFS, HR: 2.756, p = 0.014). For Her2-positive or triple-negative patients, DFS was significantly impacted by cALND omission (HR: 38.451, p = 0.030). In ER-positive Her2-negative patients, DFS, OS, RFS, and MFS were also significantly affected (HR: 2.358, 3.317, 2.538, 2.756). For 161 patients ≤ 50 years with ER-positive/Her2-negative BC, OS and BCSS were notably associated with cALND omission (HR: 103.47 and 50.874). These findings suggest a negative prognostic impact of cALND omission in patients with SN micrometastases or ITC. Omission of completion axillary lymph node dissection (cALND) in patients undergoing mastectomy with sentinel node (SN) isolated tumor cells (ITC) or micrometastases is debated due to potential under-treatment, with non-sentinel node (NSN) involvement detected in 7% to 18% of patients. This study evaluated the survival impact of cALND omission in a cohort of breast cancer (BC) patients treated by mastectomy with SN ITC or micrometastases. Among 554 early BC patients (391 pN1mi, 163 ITC), the NSN involvement rate was 13.2% (49/371). With a median follow-up of 66.46 months, multivariate analysis revealed significant associations between cALND omission and overall survival (OS, HR: 2.583, p = 0.043), disease-free survival (DFS, HR: 2.538, p = 0.008), and metastasis-free survival (MFS, HR: 2.756, p = 0.014). For Her2-positive or triple-negative patients, DFS was significantly affected by cALND omission (HR: 38.451, p = 0.030). In ER-positive Her2-negative BC, DFS, OS, recurrence-free survival (RFS), and MFS were significantly associated with cALND omission (DFS HR: 2.358, p = 0.043; OS HR: 3.317; RFS HR: 2.538; MFS HR: 2.756). For 161 patients aged ≤50 years with ER-positive/Her2-negative cancer, OS and breast cancer-specific survival (BCSS) were notably impacted by cALND omission (OS HR: 103.47, p = 0.004; BCSS HR: 50.874, p = 0.035). These findings suggest a potential negative prognostic impact of cALND omission in patients with SN micrometastases or ITC. Further randomized trials are needed. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

22. Severe perioperative morbidity after robot-assisted versus conventional laparoscopy in gynecologic oncology: Results of the randomized ROBOGYN-1004 trial

Author

Narducci, Fabrice, Bogart, Emilie, Hebert, Thomas, Gauthier, Tristan, Collinet, Pierre, Classe, Jean Marc, Lecuru, Fabrice, Delest, Alain, Motton, Stephanie, Conri, Vanessa, Ferrer, Catherine, Marchal, Frederic, Ferron, Gwenael, Probst, Alicia, Thery, Julien, Le Deley, Marie-Cécile, Lefebvre, Daniele, Francon, Daniel, Leblanc, Eric, and Lambaudie, Eric

Published
2020
Full Text
View/download PDF

23. COVID-19 et personnes suivies pour un cancer du sein : recommandations françaises pour la pratique clinique de Nice-St Paul de Vence, en collaboration avec le Collège Nationale des Gynécologues et Obstétriciens Français (CNGOF), la Société d’Imagerie de la Femme (SIFEM), la Société Française de Chirurgie Oncologique (SFCO), la Société Française de Sénologie et Pathologie Mammaire (SFSPM) et le French Breast Cancer Intergroup-UNICANCER (UCBG)

Author

Gligorov, Joseph, Bachelot, Thomas, Pierga, Jean-Yves, Antoine, Eric-Charles, Balleyguier, Corinne, Barranger, Emmanuel, Belkacemi, Yazid, Bonnefoi, Hervé, Bidard, François-Clément, Ceugnart, Luc, Classe, Jean-Marc, Cottu, Paul, Coutant, Charles, Cutuli, Bruno, Dalenc, Florence, Darai, Emile, Dieras, Veronique, Dohollou, Nadine, Giacchetti, Sylvie, Goncalves, Anthony, Hardy-Bessard, Anne-Claire, Houvenaeghel, Gilles, Jacquin, Jean-Philippe, Jacot, William, Levy, Christelle, Mathelin, Carole, Nisand, Israel, Petit, Thierry, Poncelet, Edouard, Rivera, Sofia, Rouzier, Roman, Salmon, Rémy, Scotté, Florian, Spano, Jean-Philippe, Uzan, Catherine, Zelek, Laurent, Spielmann, Marc, Penault-Llorca, Frédérique, Namer, Moise, and Delaloge, Suzette

Published
2020
Full Text
View/download PDF

29. Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome

Author

Scholl, Suzy, Popovic, Marina, de la Rochefordiere, Anne, Girard, Elodie, Dureau, Sylvain, Mandic, Aljosa, Koprivsek, Katarina, Samet, Nina, Craina, Marius, Margan, Madalin, Samuels, Sanne, Zijlmans, Henry, Kenter, Gemma, Hillemanns, Peter, Dema, Sorin, Dema, Alis, Malenkovic, Goran, Djuran, Branislav, Floquet, Anne, Garbay, Delphine, Guyon, Frédéric, Colombo, Pierre Emmanuel, Fabbro, Michel, Kerr, Christine, Ngo, Charlotte, Lecuru, Fabrice, Campo, Eleonor Rivin del, Coutant, Charles, Marchal, Frédéric, Mesgouez-Nebout, Nathalie, Fourchotte, Virginie, Feron, Jean Guillaume, Morice, Philippe, Deutsch, Eric, Wimberger, Pauline, Classe, Jean-Marc, Gleeson, Noreen, von der Leyen, Heiko, Minsat, Mathieu, Dubot, Coraline, Gestraud, Pierre, Kereszt, Attila, Nagy, Istvan, Balint, Balazs, Berns, Els, Jordanova, Ekaterina, Saint-Jorre, Nicolas de, Savignoni, Alexia, Servant, Nicolas, Hupe, Philippe, de Koning, Leanne, Fumoleau, Pierre, Rouzier, Roman, and Kamal, Maud

Published
2019
Full Text
View/download PDF

31. Triple-negative and Her2-positive breast cancer in women aged 70 and over: prognostic impact of age according to treatment

Author

Houvenaeghel, Gilles, primary, Cohen, Monique, additional, Gonçalves, Anthony, additional, Berthelot, Axel, additional, Chauvet, Marie Pierre, additional, Faure, Christelle, additional, Classe, Jean Marc, additional, Jouve, Eva, additional, Sabiani, Laura, additional, Bannier, Marie, additional, Tassy, Louis, additional, Martino, Marc, additional, Tallet, Agnès, additional, and de Nonneville, Alexandre, additional

Published
2023
Full Text
View/download PDF

32. Recommandations francophones pour la pratique clinique concernant la prise en charge des cancers du sein de Saint-Paul-de-Vence 2022-2023

Author

Gligorov, Joseph, primary, Benderra, Marc-Antoine, additional, Barthere, Xavier, additional, de Forceville, Louise, additional, Antoine, Eric Charles, additional, Cottu, Paul Henri, additional, Delaloge, Suzette, additional, Pierga, Jean-Yves, additional, Belkacemi, Yazid, additional, Houvenaegel, Gilles, additional, Pujol, Pascal, additional, Rivera, Sofia, additional, Spielmann, Marc, additional, Penault-Llorca, Frédérique, additional, Namer, Moise, additional, Aapro, Matti, additional, Al-Ghazali, Hesham, additional, Bachelot, Thomas, additional, Barranger, Emmanuel, additional, Berrada, Narjiss, additional, Bidard, François-Clément, additional, Bounedjar, Adda, additional, Boussen, Hamouda, additional, Campone, Mario, additional, Cardoso, Fatima, additional, Ceugnart, Luc, additional, Classe, Jean-Marc, additional, Cohen, Monique, additional, Coutant, Charles, additional, Cutuli, Bruno, additional, Dalenc, Florence, additional, Dieras, Véronique, additional, Dohollou, Nadine, additional, Giacchetti, Sylvie, additional, Goncalves, Anthony, additional, Freyer, Gilles, additional, Hannoun-Levi, Jean-Michel, additional, Hardy-Bessard, Anne-Claire, additional, Jacquin, Jean-Philippe, additional, Jacot, William, additional, Kerrou, Khaldoun, additional, Ladoire, Sylvain, additional, Lerebours, Florence, additional, Levy, Christelle, additional, Llombart-Cussac, Antonio, additional, Loirat, Delphine, additional, Thomassin, Isabelle, additional, Piccart, Martine, additional, Petit, Thierry, additional, Radosevic-Robin, Nina, additional, Rotenberg, Luc, additional, Rouzier, Roman, additional, Salmon, Rémy, additional, Vincent-Salomon, Anne, additional, Spano, Jean-Philippe, additional, Tallet, Agnès, additional, Teixera, Luis, additional, Tredan, Olivier, additional, Verret, Benjamin, additional, Zarca, Daniel, additional, Zelek, Laurent, additional, and Zerbib, Eric, additional

Published
2023
Full Text
View/download PDF

35. Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefit

Author

de Nonneville, Alexandre, Jauffret, Camille, Gonçalves, Anthony, Classe, Jean-Marc, Cohen, Monique, Reyal, Fabien, Mazouni, Chafika, Chauvet, Marie-Pierre, Chopin, Nicolas, Colombo, Pierre-Emmanuel, Jouve, Eva, Darai, Emile, Rouzier, Roman, Coutant, Charles, Gimbergues, Pierre, Azuar, Anne-Sophie, de Lara, Christine Tunon, Lambaudie, Eric, and Houvenaeghel, Gilles

Published
2019
Full Text
View/download PDF

37. Isolated ipsilateral local recurrence of breast cancer: predictive factors and prognostic impact

Author

Houvenaeghel, Gilles, de Nonneville, Alexandre, Cohen, Monique, Classe, Jean-Marc, Reyal, Fabien, Mazouni, Chafika, Chopin, Nicolas, Martinez, Alejandra, Daraï, Emile, Coutant, Charles, Colombo, Pierre-Emmanuel, Gimbergues, Pierre, Chauvet, Marie-Pierre, Azuar, Anne-Sophie, Rouzier, Roman, de Lara, Christine Tunon, Muracciole, Xavier, Agostini, Aubert, Gonçalves, Anthony, and Lambaudie, Eric

Published
2019
Full Text
View/download PDF

38. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study

Author

Classe, Jean-Marc, Loaec, Cecile, Gimbergues, P., Alran, S., de Lara, C. Tunon, Dupre, P. F., Rouzier, Roman, Faure, C., Paillocher, N., Chauvet, M. P., Houvenaeghel, G., Gutowski, M., De Blay, P., Verhaeghe, J. L., Barranger, E., Lefebvre, C., Ngo, C., Ferron, G., Palpacuer, C., and Campion, L.

Published
2019
Full Text
View/download PDF

39. Negative Survival Impact of Occult Lymph Node Involvement in Small HER2-Positive Early Breast Cancer Treated by Up-Front Surgery

Author

Houvenaeghel, Gilles, primary, Cohen, Monique, additional, Martino, Marc, additional, Reyal, Fabien, additional, Classe, Jean-Marc, additional, Chauvet, Marie-Pierre, additional, Colombo, Pierre-Emmanuel, additional, Heinemann, Mellie, additional, Jouve, Eva, additional, Gimbergues, Pierre, additional, Azuar, Anne-Sophie, additional, Coutant, Charles, additional, Gonçalves, Anthony, additional, and de Nonneville, Alexandre, additional

Published
2023
Full Text
View/download PDF

40. #876 Hyperthermic intraperitoneal chemotherapy in platinum-sensitive relapsed epithelial ovarian cancer: the chipor randomised phase III trial

Author

Classe, Jean-Marc, primary, Meeus, Pierre, additional, Leblanc, Eric, additional, Wernert, Romuald, additional, Quenet, François, additional, Marchal, Frédéric, additional, Houvenaeghel, Gilles, additional, Bats, Anne-Sophie, additional, Lécuru, Fabrice, additional, Ferron, Gwenaël, additional, Brigand, Cécile, additional, Berton, Dominique, additional, Gladieff, Laurence, additional, Joly, Florence, additional, Coquard, Isabelle Ray, additional, Durand-Fontanier, Sylvaine, additional, Brument, Emilie, additional, Asselain, Bernard, additional, Campion, Loïc, additional, and Glehen, Olivier, additional

Published
2023
Full Text
View/download PDF

41. Sentinel lymph node biopsy validation for large tumors

Author

Houvenaeghel, Gilles, Quilichini, Olivia, Cohen, Monique, Reyal, Fabien, Classe, Jean-Marc, Mazouni, Chafika, Giard, Sylvie, Carrabin, Nicolas, Charitansky, Hélène, Darai, Emile, Hudry, Delphine, Azuar, Pierre, Villet, Richard, Gimbergues, Pierre, Tunon-DE-Lara, Christine, and Lambaudie, Eric

Published
2017
Full Text
View/download PDF

44. Therapeutic escalation – De-escalation: Data from 15.508 early breast cancer treated with upfront surgery and sentinel lymph node biopsy (SLNB)

Author

Houvenaeghel, Gilles, Lambaudie, Eric, Cohen, Monique, Classe, Jean-Marc, Reyal, Fabien, Garbay, Jean-Rémy, Giard, Sylvia, Chopin, Nicolas, Martinez, Alejandra, Rouzier, Roman, Daraï, Emile, Colombo, Pierre Emmanuel, Coutant, Charles, Gimbergues, Pierre, Azuar, Pierre, Villet, Richard, Tunon de Lara, Christine, Barranger, Emmanuel, Sabiani, Laura, and Goncalves, Anthony

Published
2017
Full Text
View/download PDF

47. Breast cancer in young women: Pathologic features and molecular phenotype

Author

Sabiani, Laura, Houvenaeghel, Gilles, Heinemann, Mellie, Reyal, Fabien, Classe, Jean Marc, Cohen, Monique, Garbay, Jean Rémy, Giard, Sylvia, Charitansky, Hélène, Chopin, Nicolas, Rouzier, Roman, Daraï, Emile, Coutant, Charles, Azuar, Pierre, Gimbergues, Pierre, Villet, Richard, Tunon de Lara, Christine, and Lambaudie, Eric

Published
2016
Full Text
View/download PDF

48. Survival impact and predictive factors of axillary recurrence after sentinel biopsy

Author

Houvenaeghel, Gilles, Classe, Jean Marc, Garbay, Jean-Rémy, Giard, Sylvie, Cohen, Monique, Faure, Chistine, Charytansky, Hélène, Rouzier, Roman, Daraï, Emile, Hudry, Delphine, Azuar, Pierre, Villet, Richard, Gimbergues, Pierre, Tunon de Lara, Christine, Martino, Marc, Fraisse, Jean, Dravet, François, Chauvet, Marie Pierre, Goncalves, Anthony, and Lambaudie, Eric

Published
2016
Full Text
View/download PDF

50. Lymph node positivity in different early breast carcinoma phenotypes: a predictive model

Author

Houvenaeghel, Gilles, Lambaudie, Eric, Classe, Jean-Marc, Mazouni, Chafika, Giard, Sylvia, Cohen, Monique, Faure, Christelle, Charitansky, Hélène, Rouzier, Roman, Daraï, Emile, Hudry, Delphine, Azuar, Pierre, Villet, Richard, Gimbergues, Pierre, Tunon de Lara, Christine, Martino, Marc, Fraisse, Jean, Dravet, François, Chauvet, Marie Pierre, and Boher, Jean Marie

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results